Announcements Trials
Browse Landscape

Status

Recruiting 1Enrolling by invitation 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 8Observational 2

Sponsor

Cancer Type

CNS 2

Conditions

Neoplasms 267Breast Neoplasms 256Lung Neoplasms 130Prostatic Neoplasms 113Colorectal Neoplasms 106Carcinoma, Non-Small-Cell Lung 101Pancreatic Neoplasms 67Carcinoma, Hepatocellular 53Ovarian Neoplasms 50Stomach Neoplasms 49Multiple Myeloma 49Hematologic Neoplasms 48Urinary Bladder Neoplasms 47Brain Neoplasms 45Leukemia, Myeloid, Acute 42Melanoma 41Head and Neck Neoplasms 40Esophageal Neoplasms 40Disease 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Colonic Neoplasms 35Rectal Neoplasms 34Liver Neoplasms 34Lymphoma 32Neoplasm Metastasis 31Leukemia, Lymphocytic, Chronic, B-Cell 30Endometrial Neoplasms 30Uterine Cervical Neoplasms 27Thyroid Neoplasms 27Kidney Neoplasms 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Neuroma, Acoustic × 90 days × Clear all
NCT00598351 2026-06-05

Natural History Study of Patients With Neurofibromatosis Type 2

National Institutes of Health Clinical Center (CC)

Recruiting
269 enrolled
CNS

Ependymoma, Meningioma, Neurilemmoma, Neuroma, Acoustic, Spinal Cord Neoplasms, Neurofibromatoses

NCT07503613 2026-04-06

Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy

Akouos, Inc.

Enrolling by invitation
100 enrolled
CNS

Neuroma, Acoustic, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡